News

Ellen Fremion, MD, outlines strategies to support smooth transitions from pediatric to adult care, stressing early planning and strong collaboration.

Ingrid Polcari, MD, highlights concerns with teen skin care trends and emphasizes simple, age-appropriate routines tailored to patient needs.

View our Q3 2025 recap of standout pediatric news from FDA regulatory updates, clinical trial results, and expert commentary.

Experts at AAP 2025 highlight criteria, medication options, access barriers, and family engagement in pediatric obesity management.

Ingrid Polcari, MD, discusses acne severity, treatment options, and the importance of persistence and open discussion in pediatric care.

Remote monitoring in pediatrics shows promise for improving outcomes, but device design, workflow integration, and reimbursement remain key.

John Loiselle, MD, shares guidance at AAP 2025 on recognizing pediatric musculoskeletal injuries and when urgent orthopedic referral is needed.

In this video, Jeanne Marconi, MD, highlights some of the challenges providers face when implementing mental health screenings.

Take a quick look at everything you may have missed this month, including the top FDA approvals and latest clinical updates.

Explore how family-centered care and early intervention in STI prevention can transform pediatric health outcomes for future generations.

Panelists emphasize the importance of consistent screening for children and adolescents, highlighting new diagnostic tools and the need for education.

Panelists emphasize the importance of early STI screening in pediatrics, encouraging open discussions and parental involvement for better health outcomes.

Experts emphasize the critical role of access and early detection in maternal-fetal health, highlighting the need for improved STI testing and collaboration.

Explore how diagnostic stewardship enhances infection detection and treatment, especially for adolescents seeking convenient testing options.

FDA prioritizes gepotidacin, an oral gonorrhea treatment for adolescents, enhancing access and adherence in sexual health care.

Explore the latest advancements in STI screening and management, focusing on pediatric care and the critical role of early detection in newborns.

C. Buddy Creech, MD, MPH, highlights advances in mRNA, monoclonals, adjuvants, and mucosal vaccines, stressing safety and parent communication.

Thomas Crawford, MD, discusses recent data for apitegromab for SMA, as well as overall developments in the field.

From another potential treatment for pediatric atopic dermatitis, to STI therapy for uncomplicated urogenital gonorrhea, take a look ahead at key PDUFA dates in Q4.

Pediatricians can use structured visits, rating scales, and AAP guidelines to improve ADHD diagnosis, follow-up, and care coordination.

Decline in maternal smoking linked to fewer US newborns with gastroschisis, highlighting benefits of public health efforts.

Over half of youth firearm suicides involved a parent’s gun, with most stored unlocked and loaded, underscoring the need for secure storage.

Pediatric flu deaths underscore risks for healthy children and highlight importance of annual vaccination and early recognition.

Mothers with multiple adverse childhood experiences faced double the risk of preterm birth, highlighting intergenerational health effects.

Youth suicides by sodium nitrite/nitrate are rising, highlighting prevention gaps and opportunities for early medical and public health intervention.

Federal backup camera mandate cut pediatric backover injuries and deaths, though risks remain for children in older vehicles without cameras.

Nearly 1 in 4 children with firearm injuries had prior ED visits for crashes or violence, highlighting opportunities for early intervention.

FDA approves guselkumab as the first IL-23 inhibitor for children 6 years or older with plaque psoriasis or psoriatic arthritis.